| Chennai-based Asia Cryo-Cell's LifeCell, a pioneer in cord blood stem cell banking and research, has launched TRICell, its first exclusive stem cell centre for stem cell transplants and research.
|
| |
| The 10,000 sft centre, on an initial investment of Rs 5 crore, has been launched jointly with Sri Ramachandra University (SRU).
|
| |
| TRICell will exclusively cater to stem cell and bone marrow transplants for haematological and oncological disorders, S Abhaya Kumar, vice-chairman, TRICell, said.
|
| |
| "TRICell is being developed in various stages, which will enable stem cell transplantation for haematological problems and malignancies and also facilitate stem cell transplants for other specific disorders. The clinical research arm of TRICell will conduct neurological and vascular disorder clinical trials to begin with and expand its horizon to other areas in due course," Kumar said.
|
| |
| The tie-up with SRU has provided TRICell customers access to support services such as ICU, analytical and testing facilities.
|
| |
| On commencement, TRICell will support research and treatment of cancers affecting the blood -- Haemato-oncology. At a later stage, it will introduce regenerative medicine treatment methods.
|
| |
| Regenerative medicine is a concept wherein stem cells are induced to differentiate into specific cell types required to repair damaged or destroyed cell populations. Regenerative medicine is expected to be a clinical platform for all future stem cell-related work.
|
| |
| Treatments through bone marrow, allogeneic peripheral blood stem cell, mini allogeneic, autologous stem cell and cord blood transplants will be available at the centre.
|
| |
| LifeCell is a service promoted by Asia Cryo-Cell Private Ltd to propagate umbilical cord stem cell banking in India.
|
| |
| Asia Cryo-Cell has marketing and collection centres in metros like Chennai, Mumbai, New Delhi, Kolkata, Hyderabad, Bangalore, Ahmedabad, Allahabad and other cities in India. |
| |
|
| |
